文献速递慢阻肺呼吸道感染

抗菌肽水平与慢阻肺气道炎症、细菌定植及急性加重相关

Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease.
PubMed 文献 · Eur Respir J · 2017-03-15

该研究基于卑尔根慢阻肺队列(433例慢阻肺患者和325例对照),检测诱导痰中抗菌肽hCAP18/LL-37和SLPI及炎症标志物水平。稳定期慢阻肺患者痰抗菌肽水平高于对照,急性加重期hCAP18/LL-37升高而SLPI降低;稳定期高痰hCAP18/LL-37与急性加重风险增加、不可分型流感嗜血杆菌定植及炎症标志物升高相关。

要点

  • 稳定期慢阻肺患者痰抗菌肽水平高于对照,急性加重期hCAP18/LL-37升高、SLPI降低。
  • 稳定期高痰hCAP18/LL-37与急性加重风险增加和流感嗜血杆菌定植相关。
  • 抗菌肽水平变化与气道炎症、感染及慢阻肺急性加重相关。

核心结论

  • 特定抗菌肽水平改变与慢阻肺气道炎症、感染及急性加重相关,提示其在气道防御中可能起作用。

研究设计与样本

  • 卑尔根慢阻肺队列研究纳入433例慢阻肺患者和325例对照,检测诱导痰及血浆抗菌肽和炎症标志物。

主要发现

  • 稳定期慢阻肺患者(n=215)痰抗菌肽水平高于对照(n=45)。
  • 急性加重期(n=56)痰hCAP18/LL-37升高而SLPI降低,血浆hCAP18/LL-37呈相似模式。
  • 稳定期高痰hCAP18/LL-37与急性加重风险增加、不可分型流感嗜血杆菌定植、较高年龄、既往吸烟及炎症标志物升高相关。

临床怎么用

  • 痰抗菌肽水平可能有助于识别慢阻肺急性加重高风险及细菌定植患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Antimicrobial peptides (AMPs) are effectors of host defence against infection, inflammation and wound repair. We aimed to study AMP levels in stable chronic obstructive pulmonary disease (COPD) and during acute exacerbations of COPD (AECOPD), and to examine their relation to clinical parameters and inflammatory markers.The 3-year Bergen COPD Cohort Study included 433 COPD patients and 325 controls. Induced sputum was obtained and analysed for levels of the AMPs human cathelicidin (hCAP18/LL-37) and secretory leukocyte protease inhibitor (SLPI), and for the inflammatory markers interleukin (IL)-8, IL-6 and tumour necrosis factor-α (TNF-α) using immunoassays. Systemic hCAP18/LL-37 and vitamin D levels were also studied. Treating AMPs as response variables, non-parametric tests were applied for univariate comparison, and linear regression to obtain adjusted estimates. The risk of AECOPD was assessed by Cox proportional-hazard regression.Sputum AMP levels were higher in patients with stable COPD (n=215) compared to controls (n=45), and further changed during AECOPD (n=56), with increased hCAP18/LL-37 and decreased SLPI levels. Plasma hCAP18/LL-37 levels showed a similar pattern. In stable COPD, high sputum hCAP18/LL-37 levels were associated with increased risk of AECOPD, non-typeable Haemophilus influenzae colonisation, higher age, ex-smoking and higher levels of inflammatory markers.Altered levels of selected AMPs are linked to airway inflammation, infection and AECOPD, suggesting a role for these peptides in airway defence mechanisms in COPD.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Persson LJ, Aanerud M, Hardie JA, et al. Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease. Eur Respir J. 2017. PMID: 28298400. doi:10.1183/13993003.01328-2016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。